Landscapes / Companies
Hanlim Pharm. Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 3
Drugs
3
in active trials · 8 in all
Trials
1 active
9 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
HL1113not checked |
— |
Phase 3 | Dec 2028Phase 3 trial completes | ||
| Next date | Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Hypertension, Diabete Type 2 | ||||
| Open drug page | |||||
HL1113R1not checked |
— |
Phase 3 | Dec 2028Phase 3 trial completes | ||
| Next date | Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Hypertension, Diabete Type 2 | ||||
| Open drug page | |||||
HL1113R2not checked |
— |
Phase 3 | Dec 2028Phase 3 trial completes | ||
| Next date | Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Hypertension, Diabete Type 2 | ||||
| Open drug page | |||||
About
- No active trial
- Bronpass Tab., Crecheck, Entelon Tab., LuminoMark inj., Vonoprazan Test
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021